Cite

HARVARD Citation

    Morton, A. et al. (1988). Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy. BMJ. 296 (6625), pp. 811-814. [Online]. 
  
Back to record